IDEAYA Biosciences Inc. (IDYA)
NASDAQ: IDYA
· Real-Time Price · USD
26.93
1.24 (4.83%)
At close: Sep 26, 2025, 1:13 PM
IDEAYA Biosciences Revenue Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Werner Helicase Program Research And Development Service Revenue | 1.44M | 2.82M | 6.25M | 16.06M | 18.16M | 19.09M | n/a | 22.39M | 23.78M | 25.69M |
| Werner Helicase Program Research And Development Service Revenue Growth | -48.94% | -54.95% | -61.04% | -11.56% | -4.90% | n/a | -100.00% | -5.83% | -7.42% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 14.58M | 13.5M | 10.96M | 9.74M | 9.3M | 8.21M | 7.07M | 7.86M | 7.08M | 6.3M | 5.75M | 6.67M | 5.55M | 5.92M | 5.22M | 5.19M | 4.83M | 4.82M | 3.8M | 3.94M | 3.99M | 3.45M | 2.78M | 2.7M | 2.38M | 2.1M | 1.56M | 1.09M | 1.14M | 885K |
| Selling, General, and Administrative Revenue Growth | +7.98% | +23.26% | +12.46% | +4.78% | +13.21% | +16.19% | -10.11% | +11.14% | +12.30% | +9.53% | -13.72% | +20.04% | -6.23% | +13.40% | +0.71% | +7.42% | +0.25% | +26.74% | -3.53% | -1.38% | +15.70% | +24.26% | +2.89% | +13.64% | +13.25% | +34.83% | +43.01% | -4.48% | +28.70% | n/a |
| Research and Development Revenue | 74.23M | 70.89M | 140.18M | 57.15M | 54.53M | 42.8M | 38.77M | 33.7M | 29.18M | 27.86M | 24.71M | 22.37M | 22.8M | 19.66M | 16.11M | 15.5M | 14.98M | 11.57M | 12.05M | 10.02M | 8.6M | 9.03M | 8.54M | 8.92M | 8.86M | 8M | 7.58M | 12.54M | 6.43M | 5.2M |
| Research and Development Revenue Growth | +4.71% | -49.43% | +145.28% | +4.80% | +27.40% | +10.41% | +15.04% | +15.50% | +4.73% | +12.73% | +10.47% | -1.86% | +15.97% | +22.02% | +3.91% | +3.50% | +29.51% | -4.02% | +20.22% | +16.61% | -4.76% | +5.68% | -4.28% | +0.72% | +10.79% | +5.53% | -39.57% | +94.93% | +23.64% | n/a |